Organogenesis Holdings Inc.

US$0.81As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ORGOHealthcare
Country USA
PE (Fwd) •••
TSR 8Y CAGR (31.04%)
Div yield —
ROE (41.73%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 1.48
PE TTM —
TSR TTM (80.87%)
Mkt cap US$105.6M
ROIC (25.90%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.909
11.77%
(31.89%)
Hold 5|5|7|3|0
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
12.72%
16.19%
14.32%
13.59%
Revenue$M
8.879
8.988
9.228
9.491
4.80%
3.12%
3.07%
7.24%
Peers (US$105.6M)
Cap (US$)
PE
126.2M
—
110.5M
—
105.2M
7.897x
Capital
TTM
5Y
10Y
Leveragex
1.505
0.089
0.074
EBIT/Intx
1.137
1.145
1.160
Own earn%
(46.14)
(4.53)
(27.08)
Sh yield%
30.58
56.50
56.47
Owners
Insiders/Inst%
12.67
66.33
Short interest%
0.93
SBC / revenue%
5.02
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
15–25
$1 testx
−0.1
Incr. ROIC%
23